6533b86dfe1ef96bd12c9344
RESEARCH PRODUCT
KRAS-mutated intrahepatic cholangiocarcinoma shows preferential sensitivity towards PARP-1-based interventions
Fl MahnD CastvenSp PereiraM HartmannJ FahrerJb AndersenMs MatterT GaiserS RösslerPr GalleJu Marquardtsubject
business.industryPoly ADP ribose polymeraseCancer researchmedicineSensitivity (control systems)KRASmedicine.disease_causebusinessIntrahepatic Cholangiocarcinomayear | journal | country | edition | language |
---|---|---|---|---|
2020-01-01 | Zeitschrift für Gastroenterologie |